Author: sh ytlk

Combination drug therapy for childhood brain tumors shows promise in laboratory models

In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas. These cancers are the most common childhood brain cancer, accounting for up to one-third of all cases. Low grade pediatric gliomas arise in brain cells (glia) that support and nourish neurons, and current standard chemotherapies with decades-old drugs, while generally effective in lengthening life, often carry side effects or are not tolerated. Approximately 50% of children treated with traditional therapy have their tumors regrow, underscoring the need for better, targeted treatments.
Read More

Machine learning study: At least nine gender expressions exist in the brain

The terminology humans have conceived to explain and study our own brain may be mis-aligned with how these constructs are actually represented in nature. For example, in many human societies, when a baby is born either a “male” or a “female” box is checked on the birth certificate. Reality, however, may be less black and white. In fact, the assumption of dichotomic differences between only two sex/gender categories may be at odds with our endeavors that try to carve nature at its joints. Such is the case with a new paper, published recently in the journal Cerebral Cortex, where researchers argue that there are at least nine directions of brain-gender variation.
Read More